- 2024-08-20 02:10抑制剂Ralfinamide mesylate|Ralfinamide mesylate|202825-45-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RAD51 Inhibitor B02|RAD51 Inhibitor B02|1290541-46-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Raf inhibitor 2|Raf inhibitor 2|220904-99-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Raf inhibitor 2|Raf inhibitor 2|220904-99-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂R59949|R59949|120166-69-0|Adamas life|≥97%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RAD51 Inhibitor B02|RAD51 Inhibitor B02|1290541-46-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂RAD51 Inhibitor B02|RAD51 Inhibitor B02|1290541-46-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂QX77|QX77|1798331-92-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂R112|R112|575474-82-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂R112|R112|575474-82-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂R112|R112|575474-82-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Quarfloxin|Quarfloxin|865311-47-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Quarfloxin|Quarfloxin|865311-47-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Quarfloxin|Quarfloxin|865311-47-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂PZM21|PZM21|1997387-43-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂QS11|QS11|944328-88-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂QS11|QS11|944328-88-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Pyridostatin|Pyridostatin|1085412-37-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂PZ-2891|PZ-2891|2170608-82-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂PZ-2891|PZ-2891|2170608-82-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
